Blueprint Medicines Corp Business Operations Contracts & Agreements

16 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Consent and Termination Agreement between Royalty Pharma Investments 2019 ICAV and Blueprint Medicines Corporation
Termination Agreements
Blueprint Medicines Corp
Biotechnology
NY
2024
Amendment No. 2 to Collaboration and License Agreement between Blueprint Medicines Corporation and Oncopia Therapeutics, Inc.
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2023
Amendment No. 1 to Collaboration and License Agreement between Blueprint Medicines Corporation and Oncopia Therapeutics, Inc.
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2023
Mutual Termination Agreement between F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc., and Blueprint Medicines Corporation (April 30, 2023)
Termination Agreements
Blueprint Medicines Corp
Biotechnology
2023
Tenth Amendment to Collaboration and License Agreement between F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc., and Blueprint Medicines Corporation
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2022
Collaboration and License Agreement between Oncopia Therapeutics, Inc. (Proteovant Therapeutics, Inc.) and Blueprint Medicines Corporation
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
NY
2022
Ninth Amendment to Collaboration and License Agreement between F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc., and Blueprint Medicines Corporation
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2021
Eighth Amendment to Collaboration and License Agreement between F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc., and Blueprint Medicines Corporation
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2020
Seventh Amendment to Collaboration and License Agreement between F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc., and Blueprint Medicines Corporation
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2019
Sixth Amendment to Collaboration and License Agreement between F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc., and Blueprint Medicines Corporation
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2019
Fifth Amendment to Collaboration and License Agreement between F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc., and Blueprint Medicines Corporation
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2019
Fourth Amendment to Collaboration and License Agreement, effective February 25, 2019, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and the Registrant
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2019
Amendment #1 to Project Schedule #1 for Development of PMA-Ready Automated IHC IUO Enrollment Assay for FGF19 between Blueprint Medicines Corporation and Ventana Medical Systems,...
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2017
Master Collaboration Agreement between Blueprint Medicines Corporation and Qiagen Manchester Limited (August 22, 2016)
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
DE
2016
Third Amendment to Collaboration and License Agreement between F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc., and Blueprint Medicines Corporation
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2016
Second Amendment to Collaboration and License Agreement between F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc., and Blueprint Medicines
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2016